click
MyAlcon Professional Logo

My Alcon | Malaysia

This page is available in English. Select below for other locations.

Select Another Location

Clareon®
PanOptix®
Trifocal IOL

 

Ready to satisfy your patients with a full range of vision and high rate of spectacle independence?1-3

Clareon® PanOptix® Trifocal IOL

Ready to satisfy your patients with a full range of vision and high rate of spectacle independence?1-3

 

PanOptix® Provides 20/20 Vision at Near, Intermediate and Far1*†

A chart illustrating how PanOptix provides quality vision at near, intermediate, and far distances.

*Based on mean value of binocular defocus curve at near, intermediate and distance at 6 months (n=127).
†Snellen VA was converted from logMAR VA. A Snellen notation of 20/20 or better indicates a logMAR VA of 0.04 or better, which means 3 or more of the 5 ETDRS chart letters in the line were identified correctly.

Offer Your Patients Excellent Vision at Every Meaningful Distance1

 

Coffee shop with a view from the counter of coffee machines and other ingredients. A laptop is open on the countertop and an individual’s hand holds up a coffee mug to the right of the laptop screen. The image has 3 circles that zoom in on different aspects of the image. One of the circles is on the laptop screen to showcase an intermediate view with the Monofocal lens. Another circle is on the coffee mug to showcase a near view with the Monofocal lens. The last circle is on the café menu board, to showcase a far view with the Monofocal lens.
Coffee shop with a view from the counter of coffee machines and other ingredients. A laptop is open on the countertop and an individual’s hand holds up a coffee mug to the right of the laptop screen. The image has 3 circles that zoom in on different aspects of the image. One of the circles is on the laptop screen to showcase an intermediate view with the AcrySof IQ PanOptix lens. Another circle is on the coffee mug to showcase a near view with the AcrySof IQ PanOptix lens. The last circle is on the café menu board, to showcase a far view with the AcrySof IQ PanOptix lens

Vision Simulation: Daytime Activity

 

SMART Educator

Clareon® PanOptix® Provides Patients with a More Natural Intermediate Focal Point at 60 cm4

 

Our natural intermediate focal point is at arm’s length5-8

Split into 4 images side-by-side. The first image is a bird’s eye view of an individual’s hands playing the piano. The second image is of an older woman grabbing food from the fridge. The third image is of an older man sitting at his desk on his computer. The last image is of an older woman sitting on the couch with a mug in her hand while she looks at her tablet.

Clareon® PanOptix® offers a more comfortable intermediate distance for your patients at 60 cm vs 80 cm4

 

Illustration of a man looking at his phone screen. The distance from his eyes to the phone screen is 80cm. A grey ruler with text on it that reads “205cm. Above-average adult height” is placed behind the man to show his height.
Illustration of a man looking at his phone screen. The distance from his eyes to the phone screen is 80cm. A grey ruler with text on it that reads “205cm. Above-average adult height” is placed behind the man to show his height.
Other IOLs
Illustration of a man looking at his phone screen. The distance from his eyes to the phone screen is 60cm. A blue ruler with text that reads “176.5cm. Average adult height” is placed behind the man to show his height.
Illustration of a man looking at his phone screen. The distance from his eyes to the phone screen is 60cm. A blue ruler with text that reads “176.5cm. Average adult height” is placed behind the man to show his height.

Clareon PanOptix Logo

A person would need to be over 2 meters tall for 80 cm to be considered a comfortable arm's length.5-8

Proven Patient Satisfaction

 

Patients are saying yes to the PanOptix® IOL1

Almost completed blue circle with the remaining part grey. Inside the circle, text reads “99.2% of patients would have the same lens implanted again.” Underneath the circle text reads “Data collected 6 months post-op.”
Data Collected 6 Months Post-op

 

*n=127

†Response to the following question on IOLSAT questionnaire (Ver. 1.0, Dec. 20, 2018) at 6 months post-op: “Given your vision today, if you had to do it all over, would you have the same lenses implanted again?”

 

More than 9 out of 10 Patients Reported Complete Spectacle Independence

 

Patients reporting spectacle independence no longer used correction for near, intermediate or distance vision.9

White human icons in two rows side-by-side. The last human icon in the second row is faded to illustrate that “9 out of 10 patients reported complete spectacle independence.”

See Why Patients Say PanOptix® Was The Right Choice For Them

 

Placeholder for patient testimonials

Placeholder for Patient Videos

 

Placeholder video description.

Placeholder for Patient Videos

 

Placeholder video description.

Placeholder for Patient Videos

 

Placeholder video description.

PanOptix® Uses Patented ENLIGHTEN® Technology

 

 

 

See How ENLIGHTEN® Optical Technology Works

 

To make it possible to achieve 20/20 near, intermediate and distance vision – the PanOptix® IOL is equipped with a patented lens design that allows for the three optimally placed focal points.1

A complex, multi-step visual illustration describes how Enlighten Optical Technology optimises intermediate vision without compromising exceptional near and distance vision. A text box at the top, right-hand side of the page explains the first step in the Design of Enlighten Optical Technology and says “To create Enlighten Optical Technology, we first created an additional focal point at 120cm.” An image to the left of the first text box demonstrates the relationship between focal distance and light energy – highlighting 1st order intermediate. The second text box below the first text box says “Then, we redirected the new 1st order intermediate focal point’s light energy to distance.” An image to the left of the second text box demonstrates the relationship between focal distance and light energy when the new 1st order intermediate’s focal point light energy is redirected to distance. The third and final text box at the bottom of the page defines the final result and says “Enlighten Optical Technology optimises intermediate without compromising excellent near and distance vision.” An image to the left of the third text box displays how the final result optimises intermediate vision without compromising excellent near and distance vision.

PanOptix® is Engineered to Optimise Light Utilisation

Illustration of the AcrySof IQ PanOptix IOL with text inside that reads “4.5 mm” referring to the diameter of the diffractive zone within the IOL. A line coming from the top of the IOL connects to text that reads “The unique diffractive structure allows the lens to transmit 88% of light to the retina at a 3 mm pupil size for high light utilisation.” A line coming from the bottom of the IOL connects to text that reads “Featuring a 4.5 mm diffractive zone to reduce dependence on pupil size in different lighting conditions.”

PanOptix® was Recognised with Prestigious Prix Galien Award for “Best Medical Technology”

Prix Galien is an international award recognising innovative therapies. Largely considered the Nobel Prize of the biopharmaceutical and medical technology industries, Prix Galien honours innovations rigorously selected as life-changing therapeutics each year.

An image of a gold medallion that depicts the AcrySof IQ PanOptix Trifocal Intraocular Lens from Alcon as the Prix Galien USA 2021 winner for best medical technology.

PanOptix® is the Most Implanted Trifocal IOL in the World*

With over 2.2 million implants, PanOptix® is the most-implanted trifocal IOL worldwide and delivers an exceptional high-quality visual experience from far to near.1,9,12-14*

An image of gold laurels surrounding a number 1 in the shape of a caduceus that is meant to depict that PanOptix is the most implanted trifocal IOL in the world.

*Based on global Clareon® PanOptix® and AcrySof® PanOptix® unit sales 2021-2022.

Clinical Support

Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens

 

Evaluating factors that influence postoperative satisfaction in patients with diffractive EDOF and multifocal IOLs.

Lapid-Gortzak R, et al. Multicenter visual outcomes comparison of 2 trifocal presbyopia-correcting IOLs: 6-month postoperative results

 

Evaluating visual performance after implantation of a quadrifocal intraocular lens (IOL).

Kohnen T, et al. Presbyopia correction in astigmatic eyes using a toric trifocal intraocular lens with quadrifocal technology

 

Clinically evaluating the visual performance of the AcrySof® IQ PanOptix® TFNT00 and Ax LIxx tri 839MP intraocular lenses (IOLs) in binocular visual acuity (VA) and to characterize low-contrast visual performance at 6 months postimplantation.

Bohm M, et al. Defocus curves of 4 presbyopia-correcting IOL designs: Diffractive panfocal, diffractive trifocal, segmental refractive, and extended-depth-of-focus

 

Evaluating the defocus curves of 4 presbyopia-correcting intraocular lenses (IOLs).

Gundersen KG & Potvin R. Trifocal intraocular lenses: a comparison of the visual performance and quality of vision provided by two different lens designs

 

Comparing two different diffractive trifocal intraocular lens (IOL) designs, evaluating longer-term refractive outcomes, visual acuity (VA) at various distances, low contrast VA and quality of vision.

Technical Specifications14

Technical Specifications Chart Clareon PanOptix

*Based on an average pseudophakic human eye using an SRK/T optical A-constant of 119.1

Instructions for Use (IFU)

 

For a full list of indications, contraindications and warnings, please visit ifu.alcon.com and refer to the relevant product’s instructions for use.

Visit IFU Database

Alcon Experience Academy

 

For relevant training content from industry thought leaders

Visit AEA Portal

References:

1. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.

2. Bohm M, et al. Defocus curves of 4 presbyopia-correcting IOL designs: Diffractive panfocal, diffractive trifocal, segmental refractive, and extended-depth-of-focus. J Cataract Refract Surg. 2019;45:1625-1636.

3. Kohnen T, Herzog M, Hemkeppler E, et al. Visual performance of a quadrifocal (trifocal) intraocular lens following removal of the crystalline lens. Am J Ophthalmol. 2017;184:52-62. doi:10.1016/j.ajo.2017.09.016.

4. Lwowski C, et al. Visual and patient-reported factors leading to satisfaction after implantation of diffractive EDOF and trifocal intraocular lenses. J Cataract Refract Surg. 2021 Aug 18. doi: 10.1097/j.jcrs.0000000000000780.

5. Charness N, et al. Monitor viewing distance for younger and older workers. Proc Hum Factors Ergon Soc Annu Meet. 2008;52:1614-1617.

6. Average of American OSHA, Canadian OSHA and American Optometric Association Recommendations for Computer Monitor Distances. www.aoa.org. July 2015.

7. Plagenhoef S, et al. Anatomical data for analyzing human motion. Research Quarterly for Exercise and Sport. 1983;54,169-178.

8. What is the average male height? Average Height. http://www.averageheight.co/average-male-height. Accessed July 6, 2015.

9. ZHU et.al. Rate of Complete Spectacle Independence with a Trifocal IOL (PanOptix): A Systematic Literature Review and Meta-Analysis. Presentation at 2022 ASCRS; April 2022; Washington, D.C.

10. Alcon Data on File, 2014. [TDOC-0018723].

11. Alcon Data on File, 2015. [TDOC-0051365].

12. Market Scope 2022 IOL Market Report.

13. Alcon Data on File, 2022. [REF-18881].

14. Clareon® PanOptix® Trifocal IOL Directions for Use.

 

For indications, contraindications and warnings please refer to the relevant product's instruction for use​.

GC5854320-49547

GC3248421-74906

GD64236468117

GC83169342817

GD74138174717

Acrysof IQ PanOptix Trifocal IOL GC94556326617

Registered under Act 737

The content is intended for Healthcare Professionals only, not for general public

©2023 Alcon Inc. MY-ACP-2300011
Malaysia
Alcon See Briliantly